FEB 14, 2020 5:48 AM PST

Rewired natural killer cells show promising results in leukemia patients

WRITTEN BY: Tara Fernandez

Natural killer (NK) cells are a subset of white blood cells that are key players in the innate immune system, orchestrating host-rejection responses against both cancer cells and virally infected cells. Cancer researchers and drug developers are supercharging NK cells to attack malignant tissues by engineering them to express chimeric antigen receptors (CAR) in a process similar to FDA-approved T cell therapies Yescarta and Kymriah.

In a recent study published in The New England Journal of Medicine, clinical trial data shows promising results in patients with non-Hodgkin’s lymphoma or chronic lymphocytic leukemia that were treated with anti-CD19 CAR NK cells.

Significantly, the treatment was found to be effective while not triggering the flare-up of a common side effect of this type of adoptive immune cell therapy: cytokine release syndrome. 

This systemic inflammatory response, also known as an infusion reaction, is an unwanted complication that occurs when large numbers of activated immune cells are injected into a patient. Symptoms include seizures, fever, nausea, and in serious cases, cytokine release syndrome may even cause fatalities.

In the early data reported from this phase I/II trial, 73 percent of patients showed a positive response to the CAR NK therapy, with the majority of responding patients showing signs of complete remission. These responses occurred within a month after the cell therapy was administered, with CAR NK cells showing signs of persistence in the infused patients up to a year post-treatment.

Corresponding author, Katy Rezvani, MD, Ph.D., professor of stem cell transplantation and cellular therapy at The University of Texas MD Anderson Cancer Center said, “We are encouraged by the results of the clinical trial, which will launch further clinical studies to investigate allogeneic cord blood-derived CAR NK cells as a potential treatment option for patients in need.”

 

Sources: Cancer Network, The New England Journal of Medicine.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 19, 2021
Immunology
How Breastfeeding improves Infants Immunity?
JAN 19, 2021
How Breastfeeding improves Infants Immunity?
Breastfeeding benefits are well known for ages, and it has many positive impacts on infant's lives that continue wit ...
JAN 26, 2021
Immunology
COVID Vaccine Reactions: You're As Likely to Be Struck by Lightning
JAN 26, 2021
COVID Vaccine Reactions: You're As Likely to Be Struck by Lightning
In a period of just over three weeks, over four million people received Moderna’s COVID-19 vaccine. Out of all the ...
FEB 23, 2021
Immunology
Immune Link Explains Why Personality Influences Mortality
FEB 23, 2021
Immune Link Explains Why Personality Influences Mortality
University of Limerick researchers have discovered direct links between the immune system, specific personality traits, ...
MAR 23, 2021
Immunology
Assay Detects Antibodies in Asymptomatic COVID Carriers
MAR 23, 2021
Assay Detects Antibodies in Asymptomatic COVID Carriers
It is estimated that around one in five people infected with SARS-CoV-2 will not show any infection symptoms. Some of th ...
APR 29, 2021
Immunology
A Week for World Immunization
APR 29, 2021
A Week for World Immunization
The World Health Organization (WHO) is calling our attention to World Immunization Week, which comes in the last week of ...
MAY 13, 2021
Immunology
Salmonella Vaccine Uses "Molecular Telephones" to Talk to the Immune System
MAY 13, 2021
Salmonella Vaccine Uses "Molecular Telephones" to Talk to the Immune System
Salmonella infections are a massive problem—Over 95 million people are affected by this foodborne illness every ye ...
Loading Comments...